Eidos Therapeutics, Inc. Debt to Equity Ratio 2018-2020 | EIDX
Current and historical debt to equity ratio values for Eidos Therapeutics, Inc. (EIDX) over the last 10 years. The debt/equity ratio can be defined as a measure of a company's financial leverage calculated by dividing its long-term debt by stockholders' equity. Eidos Therapeutics, Inc. debt/equity for the three months ending September 30, 2020 was .
Debt/Equity Ratio Historical Data |
Date |
Long Term Debt |
Shareholder's Equity |
Debt to Equity Ratio |
2020-09-30 |
$0.04B |
$0.12B |
0.31 |
2020-06-30 |
$0.04B |
$0.15B |
0.25 |
2020-03-31 |
$0.03B |
$0.18B |
0.19 |
2019-12-31 |
$0.03B |
$0.17B |
0.19 |
2019-09-30 |
$0.02B |
$0.16B |
0.09 |
2019-06-30 |
$0.01B |
$0.13B |
0.06 |
2019-03-31 |
$0.01B |
$0.14B |
0.06 |
2018-12-31 |
$0.01B |
$0.16B |
0.03 |
2018-09-30 |
$0.01B |
$0.16B |
0.04 |
2018-06-30 |
$0.01B |
$0.17B |
0.03 |
2018-03-31 |
$0.01B |
$0.02B |
0.39 |
2017-12-31 |
$0.00B |
$0.00B |
0.66 |
2017-09-30 |
$0.00B |
|
0.00 |
2017-06-30 |
$0.00B |
|
0.00 |
2017-03-31 |
$0.00B |
|
0.00 |